Elsevier

General Hospital Psychiatry

Volume 32, Issue 6, November–December 2010, Pages 636-643
General Hospital Psychiatry

Original Contribution
Implementing composite quality metrics for bipolar disorder: towards a more comprehensive approach to quality measurement

https://doi.org/10.1016/j.genhosppsych.2010.09.011Get rights and content

Abstract

Objective

We implemented a set of processes of care measures for bipolar disorder that reflect psychosocial, patient preference and continuum of care approaches to mental health, and examined whether veterans with bipolar disorder receive care concordant with these practices.

Method

Data from medical record reviews were used to assess key processes of care for 433 VA mental health outpatients with bipolar disorder. Both composite and individual processes of care measures were operationalized.

Results

Based on composite measures, 17% had documented assessment of psychiatric symptoms (e.g., psychotic, hallucinatory), 28% had documented patient treatment preferences (e.g., reasons for treatment discontinuation), 56% had documented substance abuse and psychiatric comorbidity assessment, and 62% had documentation of adequate cardiometabolic assessment. No-show visits were followed up 20% of the time, and monitoring of weight gain was noted in only 54% of the patient charts. In multivariate analyses, history of homelessness (OR=1.61; 95% CI=1.05–2.46) and nonwhite race (OR=1.74; 95%CI=1.02–2.98) were associated with documentation of psychiatric symptoms and comorbidities, respectively.

Conclusions

Only half of patients diagnosed with bipolar disorder received care in accordance with clinical practice guidelines. High-quality treatment of bipolar disorder includes not only adherence to treatment guidelines but also patient-centered care processes.

Section snippets

Background

Bipolar disorder is a chronic illness affecting up to 5.5% of the population [1] and is associated with substantial functional limitations [2], [3] and health care costs [4], [5]. Persons with bipolar disorder often require intensive pharmacologic and psychosocial treatment [2], because the illness is uniquely characterized by alternating periods of mania and depression, which can lead to treatment interruptions and self-medication with substance abuse that impede overall treatment adherence [6]

Study population and sample

We analyzed data from a longitudinal, naturalistic, population-based study of 435 veterans with mood disorders [19]. The target population was patients being treated for bipolar disorder presenting for inpatient or outpatient care during a 2-year period (July 2004–July 2006) at a large VA mental health facility. Patients who were clinically diagnosed with bipolar disorder (including bipolar I disorder as well as the spectrum disorders including bipolar II or schizoaffective disorder–bipolar

Results

The sample (N=433) was 86% male, 77% white and had a mean age of 49 years (range 21–78). Overall, 74% of the sample was diagnosed with bipolar I, 9% diagnosed with bipolar II and 17% diagnosed with schizoaffective disorder-bipolar subtype. Half (54%) reported a history of homelessness and 28% reported a history of illicit drug use (Table 2).

The denominator was the same for each indicator (N=433). Overall, 17% had documented assessment of all symptoms (delusional, psychotic, hallucinatory), 56%

Discussion

To our knowledge, this is one of the few studies to apply operationalized processes of care that represent a wider range of services beyond medication use for patients with bipolar disorder and determine the patient factors associated with receipt of adequate processes of care in this group. This is also one of the first studies to propose patient-centered composite measures for assessing quality of care for bipolar disorder. We found that, although certain aspects of bipolar care were

References (37)

  • DennehyE.B. et al.

    Concordance with treatment guidelines for bipolar disorder: data from the systematic treatment enhancement program for bipolar disorder

    Psychopharmacol Bull

    (2007)
  • SuppesT. et al.

    Report of the texas consensus conference panel on medication treatment of bipolar disorder 2000

    J Clin Psychiatry

    (2002)
  • BlancoC. et al.

    Trends in the treatment of bipolar disorder by outpatient psychiatrists

    Am J Psychiatry

    (2002)
  • MarcusS.C. et al.

    Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder

    Am J Psychiatry

    (1999)
  • BuschA.B. et al.

    Quality of care in a Medicaid population with bipolar I disorder

    Psychiatr Serv

    (2007)
  • DonabedianA.

    The Definition of Quality and Approaches to Its Assessment. Explorations in Quality Assessment and Monitoring

    (1980)
  • DuffyF.F. et al.

    Quality of care measures for the treatment of bipolar disorder

    Psychiatr Q

    (2005)
  • BuschA.B. et al.

    Bipolar-I depression outpatient treatment quality and costs in usual care practice

    Psychopharmacol Bull

    (2008)
  • Cited by (13)

    • Does guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder?

      2021, Journal of Affective Disorders
      Citation Excerpt :

      However, concordance rates cannot be easily compared due to the differences in study designs, guidelines assessed, illness stage, bipolar disorder presentations and treatment settings. Most studies solely examined the use of pharmacotherapy although some had evaluated the use of non-pharmacological treatment options including psychoeducation (Renes et al., 2018), psychotherapy (Renes et al., 2018) or clinician assessments (Kilbourne et al., 2010). In contrast, we utilized recommendations that incorporated multimodal treatment strategies such as family psychoeducation, CBT-informed care and maintenance pharmacotherapy using prospective clinical data.

    • Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders

      2016, Journal of Substance Abuse Treatment
      Citation Excerpt :

      There are no reliable and valid process-based, quality measures that have been developed and tested for individuals with co-occurring disorders (Dausey, Pincus, & Herrell, 2009). Thus, although care for individuals with mental and/or substance use disorders varies across treatment systems (Watkins, Pincus, et al., 2011; Watkins et al., 2015), and settings (Charbonneau et al., 2003; Harris et al., 2009; Kilbourne et al., 2010; Lee et al., 2014), differences in the process of care have not been linked to differences in patient outcomes, and there are no process-based quality measures that predict improved outcomes. Thus it is unknown whether improvements in treatment process would lead to improvements in patient outcomes.

    • The impact of mood symptomatology on pattern of substance use among homeless

      2015, Journal of Affective Disorders
      Citation Excerpt :

      Bipolar depression is of particular interest in homeless populations because individuals with bipolar disorder have higher rates of homelessness, compared to those with unipolar depression (Folsom et al., 2005). Similarly, patients who had a history of homelessness have increased odds of being assessed for bipolar symptoms (Kilbourne et al., 2010). In recent studies, bipolar disorder, particularly lifetime hypomanic symptoms were found to be present in 40–44% of a Canadian homeless population (Krausz et al., 2013; Schutz et al., 2013).

    • Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder

      2012, Contemporary Clinical Trials
      Citation Excerpt :

      Global functioning was measured using the 12-item World Health Organization Disability Assessment Scale (WHO-DAS) that assesses the degree of functional impairment experienced over the past month regarding self-care, mobility, cognition, social functioning, and role functioning. Primary utilization measures of interest included outpatient primary care services, inpatient and ER use, and health care costs based on chart reviews using a standard assessment tool [69]. Patient surveys also provided information on demographic and health variables that might moderate LGCC effectiveness.

    View all citing articles on Scopus

    This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development Service (IIR 02-283) and by the National Institute of Mental Health (MH 74509; MH 79994, T32 MH19986). The funding source had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review or approval of the manuscript. All authors warrant having no actual or perceived conflicts of interest — financial or nonfinancial — in the procedures described in this manuscript. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.

    View full text